Asterias’s stem cell therapy shows promise in study

(Reuters) – Asterias Biotherapeutics Inc said initial data from a small study showed that its lead stem cell therapy could improve mobility in patients paralyzed by a spinal cord injury.









[Read the full article here]

Comments are closed.